Skip to main content

Peer Review reports

From: Treatment effect of nafamostat mesylate in patients with COVID-19 pneumonia: study protocol for a randomized controlled trial

Original Submission
24 Nov 2020 Submitted Original manuscript
24 Jun 2021 Reviewed Reviewer Report - Muslim Syed
4 Aug 2021 Reviewed Reviewer Report - Fred Stephen Sarfo
1 Oct 2021 Author responded Author comments - Kyunglan Moon
Resubmission - Version 2
1 Oct 2021 Submitted Manuscript version 2
7 Oct 2021 Reviewed Reviewer Report - Muslim Syed
24 Oct 2021 Reviewed Reviewer Report - Fred Stephen Sarfo
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
26 Oct 2021 Editorially accepted
23 Nov 2021 Article published 10.1186/s13063-021-05760-1

You can find further information about peer review here.

Back to article page